Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes https://www.nature.com/articles/s41375-025-02648-w
Discover the world at Altruu, The Discovery Engine
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes https://www.nature.com/articles/s41375-025-02648-w